(Q48566458)

12 February 2018

title

Comparative study of commercially available anti-alpha-synuclein antibodies (English)

1 reference

12 February 2018

1 reference

1 reference

E Croisier

1

1 reference

12 February 2018

D Elfant MRes

2

1 reference

12 February 2018

M Deprez

3

1 reference

12 February 2018

K Goldring

4

1 reference

12 February 2018

D T Dexter

5

1 reference

12 February 2018

R K B Pearce

6

1 reference

12 February 2018

M B Graeber

7

1 reference

12 February 2018

F Roncaroli

8

1 reference

12 February 2018

publication date

1 June 2006

1 reference

12 February 2018

Neuropathology and Applied Neurobiology

published in

1 reference

12 February 2018

volume

32

1 reference

12 February 2018

issue

3

1 reference

12 February 2018

page(s)

351-356

1 reference

12 February 2018

Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00722.X

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00722.X

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00722.X

Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00722.X

Accumulation of phosphorylated alpha-synuclein in aging human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00722.X

Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00722.X

C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00722.X

Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00722.X

The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00722.X

Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00722.X

10.1111/J.1365-2990.2006.00722.X

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018